Varex Imaging (VREX) Q3 2025

Q2 2026 Q1 2026 Q4 2025 Q3 2025

Earnings

Varex Imaging delivered a notably strong third quarter for fiscal 2025, with non-GAAP earnings of $0.18 per diluted share clearing the $0.04 consensus estimate by 414.29% and revenue of $203.00 million beating the $190.32 million forecast by 6.66%, e… Read more Varex Imaging delivered a notably strong third quarter for fiscal 2025, with non-GAAP earnings of $0.18 per diluted share clearing the $0.04 consensus estimate by 414.29% and revenue of $203.00 million beating the $190.32 million forecast by 6.66%, even as the top line slipped 2.9% year-over-year. The standout driver was margin discipline, with non-GAAP gross margin widening to 33.5% from 32.5% a year ago, pushing adjusted EBITDA to $28.90 million from $22.80 million in the prior-year quarter. Results came despite a $93.90 million goodwill impairment charge that produced a GAAP net loss of $89.10 million for the period. Industrial segment revenue held firm at $60.90 million, up 1% year-over-year, aided by growing adoption of Varex systems in cargo inspection, while the Medical segment contributed $142.10 million. Analysts have taken note of the momentum, with Wall Street projecting meaningful upside in the shares. Looking ahead, Varex guided Q4 revenue of $210.00 million to $230.00 million and expects approximately 3% full-year sales growth.